HOWL
Price
$0.80
Change
-$0.07 (-8.05%)
Updated
May 9 closing price
Capitalization
35.89M
87 days until earnings call
PHVS
Price
$16.99
Change
-$0.05 (-0.29%)
Updated
May 9 closing price
Capitalization
925.84M
Earnings call today
Ad is loading...

HOWL vs PHVS

Header iconHOWL vs PHVS Comparison
Open Charts HOWL vs PHVSBanner chart's image
Werewolf Therapeutics
Price$0.80
Change-$0.07 (-8.05%)
Volume$188.06K
Capitalization35.89M
Pharvaris
Price$16.99
Change-$0.05 (-0.29%)
Volume$15.49K
Capitalization925.84M
HOWL vs PHVS Comparison Chart
Loading...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOWL vs. PHVS commentary
May 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOWL is a StrongBuy and PHVS is a Hold.

Ad is loading...
COMPARISON
Comparison
May 12, 2025
Stock price -- (HOWL: $0.80 vs. PHVS: $16.99)
Brand notoriety: HOWL and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOWL: 76% vs. PHVS: 22%
Market capitalization -- HOWL: $35.89M vs. PHVS: $925.84M
HOWL [@Biotechnology] is valued at $35.89M. PHVS’s [@Biotechnology] market capitalization is $925.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOWL’s FA Score shows that 1 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • HOWL’s FA Score: 1 green, 4 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, PHVS is a better buy in the long-term than HOWL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOWL’s TA Score shows that 4 TA indicator(s) are bullish while PHVS’s TA Score has 6 bullish TA indicator(s).

  • HOWL’s TA Score: 4 bullish, 4 bearish.
  • PHVS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PHVS is a better buy in the short-term than HOWL.

Price Growth

HOWL (@Biotechnology) experienced а -11.60% price change this week, while PHVS (@Biotechnology) price change was -7.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

HOWL is expected to report earnings on Aug 07, 2025.

PHVS is expected to report earnings on Jul 25, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($926M) has a higher market cap than HOWL($35.9M). PHVS YTD gains are higher at: -11.372 vs. HOWL (-45.959). HOWL has higher annual earnings (EBITDA): -65.72M vs. PHVS (-127.53M). PHVS has more cash in the bank: 305M vs. HOWL (92M). PHVS has less debt than HOWL: PHVS (117K) vs HOWL (37M). HOWL has higher revenues than PHVS: HOWL (1.14M) vs PHVS (0).
HOWLPHVSHOWL / PHVS
Capitalization35.9M926M4%
EBITDA-65.72M-127.53M52%
Gain YTD-45.959-11.372404%
P/E RatioN/AN/A-
Revenue1.14M0-
Total Cash92M305M30%
Total Debt37M117K31,624%
TECHNICAL ANALYSIS
Technical Analysis
HOWLPHVS
RSI
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
87%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Ad is loading...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IZEA2.310.30
+14.93%
IZEA Worldwide
BHE34.990.18
+0.52%
Benchmark Electronics
NXST164.870.56
+0.34%
Nexstar Media Group
DLR166.57-0.13
-0.08%
Digital Realty Trust
CAPR6.34-0.63
-9.04%
Capricor Therapeutics

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with GBIO. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-8.07%
GBIO - HOWL
43%
Loosely correlated
+0.06%
AURA - HOWL
40%
Loosely correlated
-9.83%
ATOS - HOWL
39%
Loosely correlated
+0.85%
IPSC - HOWL
38%
Loosely correlated
+3.27%
ABOS - HOWL
37%
Loosely correlated
-1.99%
More

PHVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHVS has been loosely correlated with ATXS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PHVS jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
-0.29%
ATXS - PHVS
34%
Loosely correlated
-3.86%
CELC - PHVS
32%
Poorly correlated
-3.61%
SNDX - PHVS
31%
Poorly correlated
-2.82%
MLTX - PHVS
30%
Poorly correlated
-3.20%
HOWL - PHVS
30%
Poorly correlated
-8.07%
More